Beat Weidmann - Concepedia

Author

Beat Weidmann

Novartis (United States)

Also Known As

B Weidmann, B. WEIDMANN, B. Weidmann, Beat Weidmann, S Letzel, Weidmann, Beat

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)ETH Zurich Agouron Institute

About

Beat Weidmann is an author at Novartis (United States) specializing in chemistry, organic chemistry, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	9	9	916
2	Medicine	8	8	457
3	Natural Sciences	8	8	321
4	Biochemistry	7	7	307
5	Biomolecular Engineering	5	5	197

Beat Weidmann

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Organometallic Compounds of Titanium and Zirconium as Selective Nucleophilic Reagents in Organic Synthesis Beat Weidmann, Dieter Seebàch Angewandte Chemie International Edition in English Carbonyl ReactivityChemical EngineeringOrganometallic CompoundsEngineeringNovel Organocatalysts	1983	276
Titanate-Mediated Transesterifications with Functionalized Substrates Dieter Seebàch, Ernst Hungerbühler, Reto Naef, Synthesis Titanate-mediated TransesterificationsEngineeringSustainable SynthesisOrganic ChemistryCatalysis	1982	271
NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon Sue Ma, Joanna E. Boerner, Choi-Lai Tiong-Yip, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologyVarious Cyclosporine DerivativesAntiviral DrugImmunotherapy	2006	160
<i>N</i>-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity C J Hackbarth, Dawn Z. Chen, Jason G. Lewis, Antimicrobial Agents and Chemotherapy	2002	108
Selectivities in the Reactions of Alkyl‐, Aryl‐ and Heterosubstituted Organotitanium Compounds Preliminary Communication Beat Weidmann, Leo Widler, Alan G. Olivero, Helvetica Chimica Acta Organotitanium CompoundsChemical EngineeringEngineeringHeterocyclicTable 3	1981	90
Structural and Conformational Requirements for High-Affinity Binding to the SH2 Domain of Grb2 Peter Ettmayer, Dennis S. France, John Gounarides, Journal of Medicinal Chemistry Biomolecular Structure PredictionMolecular BiologyChemical BiologySh2 DomainConformational Requirements	1999	88
Methyl‐triisopropoxy‐titanium, a highly selective nucleophilic methylating reagent. Preliminary Communication Beat Weidmann, Dieter Seebàch Helvetica Chimica Acta Chemical EngineeringEngineeringOrganic ChemistryPreliminary CommunicationAbstract Replacement	1980	82
Alkyl‐, Aryl‐, Vinyl‐, and Heterosubstituted Organozirconium Compounds. ‐Selective nucleophiles of low basicity. Preliminary communication Beat Weidmann, Christopher D. Maycock, Dieter Seebàch Helvetica Chimica Acta ‐Selective NucleophilesChemical EngineeringNovel OrganocatalystsEngineeringHeterocyclic	1981	65
Peptide Deformylase Inhibitors as Antibacterial Agents: Identification of VRC3375, a Proline-3-Alkylsuccinyl Hydroxamate Derivative, by Using an Integrated Combinatorial and Medicinal Chemistry Approach D. Chen, C J Hackbarth, Zi-Jie Ni, Antimicrobial Agents and Chemotherapy	2003	59
Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents Jeanette Teo, Pamela Thayalan, David Beer, Antimicrobial Agents and Chemotherapy Antimicrobial Drug DiscoveryBiochemistryM. TuberculosisMedicineMycobacterium Tuberculosis	2006	56

Page 1